The University of Maryland Marlene and Stewart Greenebaum Cancer (UMGCCC) has attained national recognition for excellence in cancer treatment and research. 

UMGCCC is ranked as a top 20 cancer program in the country and No. 2 in Maryland, according to U.S. News & World Report. As a National Cancer Institute (NCI)-designated comprehensive cancer center, we are among the top tier of cancer centers in the country.

The following are a few more of the distinctions earned by our center to date:

  • Magnet designation by the American Nurses credentialing Center (ANCC)
  • National Accreditation Program for Breast Centers (NAPBC) for our breast program
  • Center of Excellence for treatment in Myelodysplastic Syndromes (MDS) by the Myelodysplastic Syndromes Foundation
  • American College of Surgeons Commission on Cancer (CoC) accreditation with commendation as a cancer program offering comprehensive, high-quality cancer care
  • Foundation for the Accreditation of Cellular Therapy (FACT) accreditation for blood and marrow transplant based on meeting rigorous national standards and based on the latest knowledge of the field of cellular therapy product transplantation
  • Nationally recognized as a Center of Excellence for meeting or exceeding aggressive quality of care and patient survival benchmarks by the following health insurance companies and national transplant networks:
    • Aetna Institutes of Quality
    • Blue Distinction Centers for Rare and Complex Cancers
    • Blue Distinction Centers for Transplant
    • CIGNA Life Source Transplant Network
    • Interlink Health Services Transplant Network
    • LifeTrac Transplant Network
    • OptumHealth Cancer Resource Services Network
    • OptumHealth Transplant Network